Supplements With More Than 5% Ephedrine Subject To DEA Controls
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement manufacturers whose products contain chemical mixtures of ephedrine and/or pseudoephedrine in concentrations greater than 5% have until June 30 to submit an application for registration with the Drug Enforcement Administration
You may also be interested in...
High Content Ephedra Supplements Subject To Proposed DEA Controls
Dietary supplements containing ephedrine and pseudoephedrine "mixtures" with more than 2% concentrations of either or both of the ingredients would be subject to Controlled Substances Act reporting and recordkeeping requirements under a proposed rule published by the Drug Enforcement Administration in the Sept. 16 Federal Register.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands